Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
06/2005
06/07/2005US6902900 Nucleic acid probes and methods to detect and/or quantify nucleic acid analytes
06/07/2005US6902895 Oligonucleotide matrix which uses changes in conductivity to detect hybridized nucleotide sequences; sequences determination
06/07/2005US6902891 Labeling nucleotide sequences; obtain nucleotide sequences, incubate with buffer and label, recover label nucleotide sequences
06/07/2005US6902886 Chimeric nucleic acids; recombinant host cells; fusion protein comprises a DNA binding domain for reporter gene, activation domain, and the protein of interest; modified LexA protein has no nuclear localization signal; mLexA-Gal4AD hybrid fused with
06/07/2005US6902885 For detecting viral and cellular polypeptide interactions
06/07/2005US6902735 Antibodies to human IL-17F and other CTLA-8-related proteins
06/07/2005CA2153135C Method for obtaining modified immunoglobulins with reduced immunogenicity of murine antibody variable domains and compositions containing them
06/02/2005WO2005050224A2 Small molecule and peptide arrays and uses thereof
06/02/2005WO2005049867A1 Methods for identifying modulators of quadruplex nucleic acids
06/02/2005WO2005049853A2 Compositions and methods for screening pro-apoptotic compounds
06/02/2005WO2005049849A2 Fluorescence quenching azo dyes, their methods of preparation and use
06/02/2005WO2005049848A2 Nucleic acid hybridization methods
06/02/2005WO2005049838A2 Syk-targeted nucleic acid interference
06/02/2005WO2005049832A2 FcϜRIIA-SPECIFIC NUCLEIC ACID INTERFERENCE
06/02/2005WO2005049799A2 Chimeric chemokine receptor polypeptides
06/02/2005WO2005049794A2 Methods of characterizing infectious bursal disease virus
06/02/2005WO2005049793A2 Methods and compositions for combinatorial approaches to cancer gene therapy
06/02/2005WO2005049648A2 Chimeric or fusion constructs of insulin-like growth factor binding proteins as chemotherapeutic agents
06/02/2005WO2005049639A2 Compositions and methods for protein isolation
06/02/2005WO2005035769A3 Gene silencing by using micro-rna molecules
06/02/2005WO2005033265A9 Optimized multi-epitope constructs and uses thereof
06/02/2005WO2005033158A3 Attachment of molecules to surfaces
06/02/2005WO2005028625A3 Consensus/ancestral immunogens
06/02/2005WO2005025497A3 Hpv cd8+ t-cell epitopes
06/02/2005WO2005024044A3 Method for the production of fusion proteins in transgenic mammal milk
06/02/2005WO2005012483A3 Vpr selective rnai agents and methods for using the same
06/02/2005WO2004108081A3 Oligonucleotide synthesis with alternative solvents
06/02/2005WO2004096984A3 Preservation of rna in a biological sample
06/02/2005WO2004096136A3 Compositions comprising cationic microparticles and hcv e1e2 dna and methods of use thereof
06/02/2005WO2004093797A3 Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots
06/02/2005WO2004092384A3 Means and methods for diagnosing and treating affective disorders
06/02/2005WO2004074507A8 Method to confer cell culture replication activity to different hepatitis c virus isolates
06/02/2005WO2004071414A3 Therapeutic anti-hcv (al9) compounds
06/02/2005WO2004058940A9 Sirna-mediated gene silencing
06/02/2005WO2004048255A3 Dispersion of carbon nanotubes by nucleic acids
06/02/2005WO2004037182A3 Active specific immunotherapy of cancer metastasis
06/02/2005US20050120415 Gene silencing
06/02/2005US20050120393 Nucleotide sequences associated with prostate specific gene expression for use as tool in diagnosis, prognosis, classification, prevention and treatment of cell proliferative disorders of urogenital systems
06/02/2005US20050119473 Phosphite ester oxidation in nucleic acid array preparation
06/02/2005US20050119472 GB virus C and methods of treating viral infections
06/02/2005US20050119470 Oligonucleotide sequences for use in treatment and prevention of vision and metabolic disorders; RNA interference
06/02/2005US20050119460 Gene associated with Leishmania parasite virulence
06/02/2005US20050119459 Expression vector comprising nucleotide sequences coding late-gestation lung 1 (LGL-1) for use as tool in diagnosis prevention and treatment of respiratory system disorders
06/02/2005US20050119214 Nuclease resistant double-stranded ribonucleic acid
06/02/2005US20050119208 Composition and method for treating lupus nephritis
06/02/2005US20050119201 Inhibitor of dna methylation
06/02/2005US20050118718 Stabilization and controlled delivery of ionic biopharmaceuticals
06/02/2005US20050118706 Polymer arrays
06/02/2005US20050118683 Method for producing a polypeptide
06/02/2005US20050118678 Modified polypeptide comprising amphipathic alpha -helical structure for use in prevention and treatment of infection and cell proliferative disorders
06/02/2005US20050118656 Methods for diagnosis and treatment of epithelial-derived cancers
06/02/2005US20050118651 Immunoglobulin light chain comprising variable complementarity determining regions (CDRs) for use in diagnosis, prevention and treatment of alzheimer's disease; immunotherapy; immunodiagnostics
06/02/2005US20050118635 Using cytoskeletal membrane protein concentration as diagnostic indicator of cell proliferative disorders; antitumor agents
06/02/2005US20050118634 Comparative genomic hybridization
06/02/2005US20050118628 Synthesizing polynucleotide sequences based on model generated sequences; bioinformatics; directed evolution of proteins
06/02/2005US20050118624 Anitbiotic ligand and fluorophore; for high throughput screening
06/02/2005US20050118623 Single nucleotide polymorphism analysis of highly polymorphic target sequences
06/02/2005US20050118621 Methods for labeling nucleotides, labeled nucleotides and useful intermediates
06/02/2005US20050118617 Solid phase synthesis; microarrays
06/02/2005US20050118611 Thioaptamers enable discovery of physiological pathways and new therapeutic strategies
06/02/2005US20050118589 Digital array
06/02/2005US20050118579 Using allelic variation in canalicular multispecific organic anion transporter (cMOAT) gene as diagnostic tool in detection of liver and bile duct disorders
06/02/2005US20050118564 Using endothelial and smooth cell artery wall models to capture the cell-cell and cell-matrix communications that are operative in normal and diseases conditions; diagnosis and treatment of cell proliferative and vascular disorders
06/02/2005US20050118183 Anti-CD33 antibodies and method for treatment of acute myeloid leukemia using the same
06/02/2005US20050118179 Prostate apoptosis response-4 (Par-4) mutants which cause apoptosis in sensitive cancer cells; kits, vectors, and polypeptides
06/02/2005US20050118176 Inhibiting binding of interleukin-4 (IL-4) to an IL-4 Receptor; suppressing an IL-4-dependent immune or inflammatory response in a mammal
06/02/2005US20050118169 For inflammatory diseases; rheumatoid arthritis; hybridoma cell lines
06/02/2005US20050118159 recombinant DNA molecules that express homogenous lysostaphin and host cells transformed with these DNA molecules
06/02/2005US20050118151 Drug screening; proteins that can be used as targets for the treatment of diabetes
06/02/2005US20050118117 Methods for identifying risk of melanoma and treatments thereof
06/02/2005DE10350256A1 PIM-1-spezifische siRNA-Verbindungen PIM-1 specific siRNA compounds
06/02/2005DE10349441A1 Selecting nucleic acid that binds target molecules, useful potentially as therapeutic agents, by screening short sequences with two fixed regions flanking a random region
06/02/2005CA2546840A1 Immunization against chlamydia infection
06/02/2005CA2546836A1 Immunization against chlamydia infection
06/02/2005CA2546383A1 Rescue agents for treating botulinum toxin intoxications
06/02/2005CA2546074A1 Syk-targeted nucleic acid interference
06/02/2005CA2546067A1 Fcyriia-specific nucleic acid interference
06/02/2005CA2545886A1 Methods of characterizing infectious bursal disease virus
06/02/2005CA2543897A1 Compositions and methods for screening pro-apoptotic compounds
06/01/2005EP1534865A2 Methods and compositions for determining methylation profiles
06/01/2005EP1534861A1 Sirna-mediated gene silencing with viral vectors
06/01/2005EP1534859A2 Methods of detecting sequence differences
06/01/2005EP1534857A2 Methods and compositions for detection and analysis of polynucleotides using light harvesting multichromophores
06/01/2005EP1534837A2 Apicomplexan pathways, inhibitiors, and drug delivery
06/01/2005EP1534744A1 Altered insulin-like growth factor binding proteins
06/01/2005EP1534736A2 Nogo receptor antagonists
06/01/2005EP1534731A1 Bmp-2 estrogen responsive element and methods of using the same
06/01/2005EP1534730A2 Modified transferin-antibody fusion proteins
06/01/2005EP1534729A2 Variants of nedd4l associated with hypertension and viral budding
06/01/2005EP1534728A2 Antisense modulation of glucocorticoid receptor expression
06/01/2005EP1534318A2 Methods and compositions for manipulating the guided navigation of endothelial tubes during angiogenesis
06/01/2005EP1451291A4 Methods for identifying, isolating, and controlling the growth of estrogen-responsive cells
06/01/2005EP1124838B1 Nucleic acid labeling compounds
06/01/2005EP1117478B1 Support for a method for determining an analyte and a method for producing the support
06/01/2005EP0936951B1 Methods for producing low binding surfaces
06/01/2005EP0794963B1 Xanthine derivatives compounds useful for activating chloride conductance in animal cells
06/01/2005CN1622995A Receptor nucleic acids and polypeptides
06/01/2005CN1621529A Micro-nucleic acid releasing agent
06/01/2005CN1621523A Adenosine phosphate-ribosylation-factor 1 gene in cotton and its promoter
06/01/2005CN1621414A Antigenic determinant polypeptide of human tumor-testis antigen HCA587 and use thereof
1 ... 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 ... 899